Medicine and Dentistry
Anaplastic Thyroid Carcinoma
91%
Overall Survival
70%
Neck
66%
Diseases
61%
Radiation Therapy
59%
Thyroid Cancer
53%
Vestibular Schwannoma
46%
Neoplasm
44%
Meta-Analysis
44%
Microsurgery
36%
Thyroid Gland
34%
Head and Neck Cancer
34%
Conservative Treatment
33%
Chronic Rhinosinusitis
33%
Cancer
30%
Recurrent Disease
29%
Functional Endoscopic Sinus Surgery
29%
Differentiated Thyroid Cancer
27%
Neck Dissection
25%
Malignant Neoplasm
22%
Sentinel Lymph Node Biopsy
22%
Surgical Oncology
22%
Progression Free Survival
19%
Clinical Trial
18%
Surgeon
17%
Head and Neck Squamous Cell Carcinoma
17%
Retrospective Cohort Study
16%
Systematic Review
16%
Wound
13%
Biological Marker
13%
Surgical Approach
12%
Squamous Cell Carcinoma
12%
Targeted Therapy
12%
Microbiome
12%
Xenograft
12%
Primary Tumor
12%
Papillary Thyroid Cancer
12%
Adverse Event
12%
Hazard Ratio
11%
Optical Coherence Tomography
11%
Eustachian Tube
11%
Pure Tone Audiometry
11%
Tumor Classification
11%
Thyroid Surgery
11%
Salivary Gland
11%
Osteonectin
11%
Chemoradiation Therapy
11%
Trachea
11%
Neurofibromatosis Type II
11%
Dabrafenib
11%
Keyphrases
Anaplastic Thyroid Cancer
100%
Overall Survival
47%
Head-and-neck
41%
Meta-analysis
33%
BRAF V600E
25%
Radiation Therapy
23%
Thyroid Cancer
23%
Vestibular Schwannoma
22%
Chronic Rhinosinusitis
22%
Intraoperative Radiation Therapy
22%
Stereotactic Radiation
22%
Head-and-neck Cancer
22%
Surgical Oncology
22%
Neck Dissection
18%
Endoscopic Sinus Surgery
18%
Confidence Interval
17%
Patient-derived Xenograft
17%
Retrospective Cohort Study
17%
Thyroid Disease
16%
Differentiated Thyroid Cancer
16%
Direct Therapy
15%
Neoadjuvant
14%
Clinical Trials
14%
Targeted Therapy
14%
Survival Outcomes
13%
Median Overall Survival
13%
Surgical Approach
12%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
12%
Primary Tumor
12%
Recent Advances
11%
Locoregional
11%
Special Treatment
11%
Advanced Thyroid Cancer
11%
Locoregionally Advanced
11%
Eustachian Tube
11%
Sentinel Lymph Node Biopsy
11%
COVID-19 Pandemic
11%
Intermediate Grade
11%
Biopsy Outcomes
11%
Genetically Engineered Mouse Models
11%
Optical Coherence Tomography
11%
Multidisciplinary Groups
11%
Initial Management
11%
Serum Biomarkers
11%
Single Center
11%
Collaborative Research
11%
Trametinib
11%
Cancer Management
11%
Checkpoint Inhibition
11%
Group Consensus
11%
Pharmacology, Toxicology and Pharmaceutical Science
Anaplastic Thyroid Carcinoma
82%
Overall Survival
54%
Chronic Rhinosinusitis
44%
Diseases
35%
Microbiome
23%
Head and Neck Cancer
23%
Staphylococcus aureus
23%
Azithromycin
22%
Malignant Neoplasm
21%
Thyroid Cancer
20%
Neoplasm
18%
Progression Free Survival
17%
Cohort Study
17%
Differentiated Thyroid Cancer
16%
Clinical Trial
16%
Recurrent Disease
15%
Chemoradiation Therapy
14%
Biological Marker
14%
Adverse Event
13%
Squamous Cell Carcinoma
12%
Osteonectin
11%
Cancer Recurrence
11%
Trametinib
11%
Thyroid Disease
11%
Dabrafenib
11%
Pembrolizumab
11%
Genetically Engineered Mouse Strain
11%
Mouse Model
11%
Lactate Dehydrogenase
11%
Neurilemoma
11%
Inflammation
11%
Thyroid Medullary Carcinoma
11%
Vertigo
8%
Placebo
7%
Auditory Tube Dysfunction
6%
Lactic Acid
6%
Cancer Inhibition
6%
Head and Neck Squamous Cell Carcinoma
6%
Combination Therapy
5%
Immunotherapy
5%
Tinnitus
5%
Hearing Impairment
5%
Dizziness
5%